| 430 |
Binding of SARS-CoV-2 to ACE2 leads to viral infection proliferation |
Sally Mayasich |
BY-SA |
1739: Binding to ACE2
|
1939: Viral infection and host-to-host transmission, proliferated
|
Under Development |
1.96 |
| 429 |
A cholesterol/glucose dysmetabolism initiated Tau-driven AOP toward memory loss (AO) in sporadic Alzheimer's Disease with plausible MIE's plug-ins for environmental neurotoxicants |
Erwin L Roggen |
BY-SA |
None
|
1941: Memory Loss
|
|
|
| 428 |
Binding of S-protein to ACE2 in enterocytes induces ACE2 dysregulation leading to gut dysbiosis |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
None
|
Under Development |
1.96 |
| 427 |
ACE2 downregulation following SARS-CoV-2 infection triggers dysregulation of RAAS and can lead to heart failure. |
Evangelos-Panagiotis Daskalopoulos |
BY-SA |
1739: Binding to ACE2
|
1535: Heart failure
|
|
|
| 426 |
SARS-CoV-2 spike protein binding to ACE2 receptors expressed on pericytes leads to endothelial cell dysfunction, microvascular injury and myocardial infarction. |
Evangelos-Panagiotis Daskalopoulos |
BY-SA |
1739: Binding to ACE2
|
1934: Myocardial Infarction
|
|
|
| 425 |
Oxidative Stress Leading to Decreased Lung Function via Decreased FOXJ1 |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 424 |
Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 423 |
Toxicological mechanisms of hepatocyte apoptosis through the PARP1 dependent cell death pathway |
Fei Li |
BY-SA |
2 MIEs
|
1817: Apoptotic cell death
|
|
|
| 422 |
Binding of SARS-CoV-2 to ACE2 in enterocytes leads to intestinal barrier disruption |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
None
|
Under Development |
1.96 |
| 421 |
PPARG activation leading to intrahepatic cholestasis |
Yuan Jin |
BY-SA |
None
|
None
|
|
|
| 420 |
Aryl hydrocarbon receptor activation leading to lung cancer through sustained NRF2 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
None
|
|
|
| 419 |
Aryl hydrocarbon receptor activation leading to impaired lung function through P53 toxicity pathway |
Dianke Yu |
BY-SA |
None
|
1250: Decrease, Lung function
|
|
|
| 418 |
Aryl hydrocarbon receptor activation leading to impaired lung function through AHR-ARNT toxicity pathway |
Dianke Yu |
BY-SA |
None
|
None
|
|
|
| 417 |
Aryl hydrocarbon receptor activation leading to lung cancer through AHR-ARNT toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
1670: Lung cancer
|
|
|
| 416 |
Aryl hydrocarbon receptor activation leading to lung cancer through IL-6 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
1670: Lung cancer
|
|
|
| 415 |
Aryl hydrocarbon receptor activation leading to lung fibrosis through IL-6 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
1276: Lung fibrosis
|
|
|
| 414 |
Aryl hydrocarbon receptor activation leading to lung fibrosis through TGF-β dependent fibrosis toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
None
|
|
|
| 413 |
Oxidation and antagonism of reduced glutathione leading to mortality via acute renal failure |
Carmel Mothersill |
BY-SA |
926: Oxidation, Glutathione (To be considered with MIE)
|
351: Increased Mortality
|
|
|
| 412 |
Endothelial cell dysfunction leading to thromboinflammation |
Luigi Margiotta-Casaluci |
BY-SA |
None
|
1916: Thromboinflammation, Increased
|
Under Development |
1.96 |
| 411 |
Oxidative stress Leading to Decreased Lung Function |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 410 |
GSK3beta inactivation leading to increased mortality via defects in developing inner ear |
Vid Modic |
BY-SA |
1647: GSK3beta inactivation
|
2 AOs
|
|
|
| 409 |
Frustrated phagocytosis leads to malignant mesothelioma |
Penny Nymark |
BY-SA |
1668: Frustrated phagocytosis
|
1090: Increased, mesotheliomas
|
|
|
| 408 |
Imbalance in redox homeostasis leading to structural damage to tissues |
Fei Li |
BY-SA |
None
|
None
|
|
|
| 407 |
SARS-CoV-2 infection leading to pyroptosis |
Hasmik Yepiskoposyan |
BY-SA |
1739: Binding to ACE2
|
1967: Pyroptosis
|
|
|
| 406 |
SARS-CoV-2 infection leading to hyperinflammation |
Hasmik Yepiskoposyan |
BY-SA |
1739: Binding to ACE2
|
1868: Hyperinflammation
|
|
|